No Data
Quanterix Buy Rating Supported by Instrument Sales Recovery, Strategic Growth Opportunities, and Promising Market Potential
CCORF Maintains Quanterix(QTRX.US) With Buy Rating, Maintains Target Price $20
Canaccord Genuity Reaffirms Their Buy Rating on Quanterix (QTRX)
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Quanterix (QTRX) and Walgreens Boots Alliance (WBA)
Quanterix Narrows FY24 Revenue View to $137.2M From $134M-$138M
Quanterix Reported Q4 Revenue Of $34.9M, Up 11% YoY, Cash Balance Of 44.4M
152398576 : your update made me a buck
Trytosaveabit OP 152398576 : That’s awesome congrats
! But you made the trade! I just pointed in the proper direction for a possible move! Hehehe